• J Gen Intern Med · Jul 2020

    Review

    EVALI and the Pulmonary Toxicity of Electronic Cigarettes: A Review.

    • Lydia Winnicka and Mangalore Amith Shenoy.
    • Department of Pulmonary and Critical Care Medicine, NYU Winthrop Hospital, 222 Station Plaza North, Suite 400, Mineola, NY, 11501, USA. lydiawinnicka@gmail.com.
    • J Gen Intern Med. 2020 Jul 1; 35 (7): 2130-2135.

    AbstractElectronic cigarettes are a novel and emerging product increasingly used by the general public. However, despite their popularity, they remain poorly studied and with likely serious health risks. EVALI, or "electronic cigarette or vaping product use-associated lung injury," is a recently described entity at the forefront of current investigations. Though EVALI has been linked to vitamin E acetate, a constituent of THC vaping products, electronic cigarettes likely pose a host of other pulmonary toxicities. The presentation, diagnostic work-up, treatment, and pathophysiology of EVALI are herein described, as well as the general pulmonary toxicity profile of electronic cigarettes.

      Pubmed     Free full text   Copy Citation  

      Add institutional full text...

    Notes

    hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,704,841 articles already indexed!

We guarantee your privacy. Your email address will not be shared.